Eagle Global Advisors LLC Abb Vie Inc. Transaction History

Eagle Global Advisors LLC

$1.74 Billion
Q1 2024

A detailed history of Eagle Global Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eagle Global Advisors LLC holds 66,581 shares of ABBV stock, worth $11 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

66,581

Previous 3,297 1919.44%

Holding current value

$11 Million

Previous $510,000 2277.25%

% of portfolio

0.7%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $10.1 Million - $11.5 Million	63,284 Added 1919.44%	66,581 $12.1 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $63,708 - $71,751	463 Added 16.34%	3,297 $510,000
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $26,502 - $32,980	200 Added 7.59%	2,834 $381,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $13,831 - $16,587	100 Added 3.95%	2,634 $425,000
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $36,907 - $42,330	275 Added 12.17%	2,534 $340,000

Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $240,357 - $272,842	-2,259 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $181,826 - $245,485	2,259 New	2,259 $242,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $34,364 - $40,332	-400 Reduced 12.27%	2,859 $250,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $243,955 - $326,448	-3,325 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $12,061 - $18,286	-187 Reduced 5.32%	3,325 $253,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $7,213 - $9,025	-100 Reduced 2.77%	3,512 $311,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $74,001 - $88,971	-1,175 Reduced 24.55%	3,612 $274,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $3,285 - $4,199	50 Added 1.06%	4,787 $348,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $84,854 - $99,869	-1,100 Reduced 18.85%	4,737 $382,000
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $116,774 - $144,015	-1,500 Reduced 20.44%	5,837 $538,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $177,820 - $197,680	-2,000 Reduced 21.42%	7,337 $694,000
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $111,608 - $149,453	-1,213 Reduced 11.5%	9,337 $884,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $8,956 - $9,821	100 Added 0.96%	10,550 $1.02 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $729,932 - $932,349	10,450	10,450 $929,000

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Account

Eagle Global Advisors LLC Abb Vie Inc. Transaction History